Nilogen Oncosystems is a leading brand based in Tampa, FL, that offers innovative 3D cancer models using their patented 3D-EXplore technology. These models are created from fresh human tumor tissue and are designed to fully capture tumor heterogeneity, providing a more accurate understanding of therapeutic response. With up to 9,000 tumoroids created from each patient's tumor, Nilogen ensures the retention of an intact tumor microenvironment (TME) and the capture of the complete tumor's heterogeneity.

This technology reflects clinical response rates, making it a valuable tool for translational immuno-oncology programs. Nilogen's services include tumor cell killing analysis, cytokine analysis, gene expression and proteomics analysis, high content imaging, flow cytometry, and multiplex IHC. Their advanced bioinformatics and artificial intelligence algorithms deliver highly actionable insights to drive accurate decision-making for drug development programs.

Partner with Nilogen Oncosystems to improve the success of your oncology therapies and enhance the quality of life for cancer patients